Market Overview:
The global tumor ablation equipment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cancer, technological advancements in tumor ablation equipment, and rising demand for minimally invasive procedures. Based on type, the global tumor ablation equipment market is segmented into microwave ablation (MWA), radiofrequency ablation (RFA), cryoablation, and others. MWA held the largest share of the global tumor ablations market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to its advantages such as low invasiveness, short treatment time, and high efficacy rates. Based on application, hospitals accounted for majority of revenue generated by this market in 2017; however clinics are projected to witness highest growth rate during forecast period owing growing preference for outpatient procedures over hospital-based treatments across developed countries such as U.S.
Product Definition:
Tumor ablation is a minimally invasive surgical technique that uses energy to destroy cancer cells. This type of surgery is performed using equipment such as lasers, microwaves, or radiofrequency waves. Tumor ablation can be used to treat many types of cancer, including liver cancer, lung cancer, and breast cancer.
MicrowaveAblation，MWA:
The global microwave ablation market size was valued at USD 859.7 million in 2016 and is expected to grow at a CAGR of XX% over the forecast period.
Radiofrequency Ablation，RFA:
Radiofrequency Ablation (RFA) is a minimally invasive surgical procedure used to treat patients suffering from life-threatening diseases such as malignant tumors. The RFA equipment market is expected to witness lucrative growth over the forecast period owing to factors such as increasing prevalence of cancer, technological advancements in RFA devices, and rising demand for ablation procedures.
Application Insights:
Based on the application, the global tumor ablation equipment market is segmented into hospitals and clinics. Hospitals held the largest share in 2017 owing to availability of advanced healthcare facilities and highly skilled staff at major cities across countries such as India, China, Japan. Furthermore, rising prevalence of cancer coupled with increasing number of procedures requiring ablation makes it necessary for patients to travel to seek medical care which encourages adoption in hospitals.
Clinic-based treatment is preferred by many patients as they can access advanced treatment centers remotely or travel for a same-day procedure if an emergency situation demands it be performed immediately upon arrival at a hospital. The growing preference for minimally invasive treatments has contributed significantly towards growth in this segment over recent years due to introduction of technologically advanced devices that are user friendly and easy to operate without compromising on quality or safety standards expected from any medical device used within a clinical setting.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of players, high adoption rate for advanced technologies, and favorable reimbursement policies. The U.S. is one of the most lucrative markets for medical devices as it has one of the highest healthcare expenditure levels globally and this trend is expected to continue over the forecast period.
In 2014, CryoLife Corporation acquired Ablation Technology Inc., a provider of cryogenic tumor ablation equipment based in Canada that had been developing MWA systems since 2007’s It also purchased GlobalMed Medical Technologies Inc.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for tumor ablation equipment market. According to World Health Organization (WHO), in 2012, there were 14 million new cases of cancer and 8.2 million deaths due to cancer worldwide. This number is expected to increase by about 70% over the next two decades, accounting for 21.7 million new cases and 13 million deaths in 2030. This will create a large demand for tumor ablation equipment, which will drive the market growth during the forecast period
- Technological advancements: Tumor ablation technology has evolved significantly over last few years with advent of novel technologies such as microwave ablation, radiofrequency ablation (RFA), and laser interstitial thermal therapy (LITT). These technologies are less invasive than traditional surgery and offer better outcomes with fewer side effects, which is driving their adoption among patients globally
- Growing awareness about benefits of tumor ablations: There is growing awareness among patients regarding benefits associated with tumor ablations such as improved quality of life, reduced treatment costs, and shorter hospital stays compared to traditional surgery procedures. This is fueling demand for these devices globally
Scope Of The Report
Report Attributes
Report Details
Report Title
Tumor Ablation Equipment Market Research Report
By Type
MicrowaveAblation，MWA, Radiofrequency Ablation，RFA, Cryoablation, Others
By Application
Hospitals, Clinic
By Companies
Medtronic, Johnson & Johnson, Boston Scientific Corporation, Ice Cure Medical Ltd., Galil Medical(BTG), HYGEA, Haifu, welfare, ECO, Nanjing Greatwall Information System Co., Medtronic
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
228
Number of Tables & Figures
160
Customization Available
Yes, the report can be customized as per your need.
Global Tumor Ablation Equipment Market Report Segments:
The global Tumor Ablation Equipment market is segmented on the basis of:
Types
MicrowaveAblation，MWA, Radiofrequency Ablation，RFA, Cryoablation, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Johnson & Johnson
- Boston Scientific Corporation
- Ice Cure Medical Ltd.
- Galil Medical(BTG)
- HYGEA
- Haifu
- welfare
- ECO
- Nanjing Greatwall Information System Co.
- Medtronic
Highlights of The Tumor Ablation Equipment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- MicrowaveAblation，MWA
- Radiofrequency Ablation，RFA
- Cryoablation
- Others
- By Application:
- Hospitals
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tumor Ablation Equipment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tumor ablation equipment is a medical device used to destroy cancerous tumors. It uses high-energy beams and heat to damage or vaporize the tumor.
Some of the major players in the tumor ablation equipment market are Medtronic, Johnson & Johnson, Boston Scientific Corporation, Ice Cure Medical Ltd., Galil Medical(BTG), HYGEA, Haifu, welfare, ECO, Nanjing Greatwall Information System Co., Medtronic.
The tumor ablation equipment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tumor Ablation Equipment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tumor Ablation Equipment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tumor Ablation Equipment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tumor Ablation Equipment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tumor Ablation Equipment Market Size & Forecast, 2018-2028
4.5.1 Tumor Ablation Equipment Market Size and Y-o-Y Growth
4.5.2 Tumor Ablation Equipment Market Absolute $ Opportunity
Chapter 5 Global Tumor Ablation Equipment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Tumor Ablation Equipment Market Size Forecast by Type
5.2.1 MicrowaveAblation，MWA
5.2.2 Radiofrequency Ablation，RFA
5.2.3 Cryoablation
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Tumor Ablation Equipment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Tumor Ablation Equipment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tumor Ablation Equipment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tumor Ablation Equipment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Tumor Ablation Equipment Analysis and Forecast
9.1 Introduction
9.2 North America Tumor Ablation Equipment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Tumor Ablation Equipment Market Size Forecast by Type
9.6.1 MicrowaveAblation，MWA
9.6.2 Radiofrequency Ablation，RFA
9.6.3 Cryoablation
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Tumor Ablation Equipment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Tumor Ablation Equipment Analysis and Forecast
10.1 Introduction
10.2 Europe Tumor Ablation Equipment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Tumor Ablation Equipment Market Size Forecast by Type
10.6.1 MicrowaveAblation，MWA
10.6.2 Radiofrequency Ablation，RFA
10.6.3 Cryoablation
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Tumor Ablation Equipment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Tumor Ablation Equipment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Tumor Ablation Equipment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Tumor Ablation Equipment Market Size Forecast by Type
11.6.1 MicrowaveAblation，MWA
11.6.2 Radiofrequency Ablation，RFA
11.6.3 Cryoablation
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Tumor Ablation Equipment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Tumor Ablation Equipment Analysis and Forecast
12.1 Introduction
12.2 Latin America Tumor Ablation Equipment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Tumor Ablation Equipment Market Size Forecast by Type
12.6.1 MicrowaveAblation，MWA
12.6.2 Radiofrequency Ablation，RFA
12.6.3 Cryoablation
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Tumor Ablation Equipment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Tumor Ablation Equipment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Tumor Ablation Equipment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Tumor Ablation Equipment Market Size Forecast by Type
13.6.1 MicrowaveAblation，MWA
13.6.2 Radiofrequency Ablation，RFA
13.6.3 Cryoablation
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Tumor Ablation Equipment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tumor Ablation Equipment Market: Competitive Dashboard
14.2 Global Tumor Ablation Equipment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 Johnson & Johnson
14.3.3 Boston Scientific Corporation
14.3.4 Ice Cure Medical Ltd.
14.3.5 Galil Medical(BTG)
14.3.6 HYGEA
14.3.7 Haifu
14.3.8 welfare
14.3.9 ECO
14.3.10 Nanjing Greatwall Information System Co.
14.3.11 Medtronic
